Related Experiment Video
Updated: Jul 1, 2025
11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
3.8K
[Emphasizing the timing and procedure selection for vitrectomy in pathological myopic traction maculopathy].
1Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Institute of Ophthalmology, Beijing Key Laboratory of Ophthalmology & Visual Sciences, Beijing 100730, China.
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|March 10, 2024
Summary
Pathologic myopia can cause irreversible vision loss due to myopic maculopathy. Surgical techniques like vitrectomy are crucial for treating myopic traction maculopathy, improving patient outcomes.
Area of Science:
- Ophthalmology
- Retinal Surgery
Context:
- Myopic maculopathy is a leading cause of irreversible vision loss in pathologic myopia.
- Myopic traction maculopathy (MTM) is a common complication requiring surgical intervention.
Purpose:
- To outline surgical strategies for various types of MTM.
- To emphasize the importance of timely surgical intervention and technique selection.
Summary:
- MTM includes epiretinal membrane, foveoschisis, macular hole, and macular hole-related retinal detachment.
- Specific surgical approaches are recommended: vitrectomy with ILM peeling for Type II ERM, foveal-sparing ILM peeling for foveoschisis, inverted ILM flap for macular holes, and vitrectomy with macular buckle for refractory MHRD.
Impact:
- Accurate surgical timing and technique selection are vital for maximizing patient benefits in MTM.
- This approach aims to preserve and improve vision in patients with complex myopic retinal conditions.
